COVID Studies Concerns

Two of the world’s heading pharmaceutical journals on Tuesday showed concern about potential flaws in the data and covid studies provided by a little company…




The Antiviral Effect On COVID

Gilead Sciences, Inс has published topline outcomes from the Phase 3 SIMPLE trial in hospitalized sufferers with COVID infection. This open-label research estimated 5-day and…







Smoking Cessation Report

In January, the Surgeon General issued the first report on smoking cessation in 30 years. The news refreshes the latest findings on smoking cessation in…